Federal jury rules against ACell and for Cook Biotech and Purdue Research Foundation in patent infringement verdict
A jury in the Federal Court for the Northern District of Indiana has found that Jessup, Md.-based ACell Inc.'s tissue-engineered biomaterial infringes a key tissue-engineering patent owned by Purdue Research Foundation and licensed to Cook Biotech.
Read Full Article (July 11, 2005)

FDA Clears Cook's AFP Fistula Plug As First Medical Device For Fistula Repair
The U.S. Food and Drug Administration has cleared the Surgisis® AFP™ Fistula Plug as the first and only surgical device for repair of fistulas, Cook Biotech Incorporated announced today.
Read Full Article (April 28, 2005)

Cook Biotech, CorMatrix Cardiovascular Announce Agreements Related to Engineered Tissue Technologies
Cook Biotech Incorporated and CorMatrix Cardiovascular Incorporated are pleased to announce a recently established cross-license agreement.
Read Full Article (February 24, 2005)

Cook Biotech "Marches In" to New Expansion
Cook Biotech Incorporated cuts the ribbon today to unveil a new 55,000-square-foot manufacturing, research and development facility.
Read Full Article (September 10, 2004)

Cook Biotech donates biomaterial to help wounded children in Afghanistan
Cook Biotech Inc. is sending some of its wound-healing biomaterial to Afghanistan to help children injured there during the war and its aftermath.
Read Full Article (April 8, 2004)

FDA Clears Durasis® Dural Substitute from Cook Biotech for U.S. Sales
The U.S. Food and Drug Administration has granted Cook Biotech Incorporated clearance to sell DURASIS® Dural Substitute in the United States.
Read Full Article (December 3, 2003)

Doctors Share Interim Findings, Results Offer Promise that Ulcers Treated with OASIS® Wound Matrix may be "More Likely to Heal"
Jeffrey A. Niezgoda, M.D., F.A.C.E.P., and Eliot N. Mostow, M.D., M.P.H., physicians participating in two separate clinical studies designed to evaluate products and standards of care in the management of hard-to-heal wounds, announced interim analysis on the performance of OASIS Wound Matrix, where over 1,000 clinicians attended a recent clinical symposium in Chicago.
Read Full Article

Cook Biotech Launches New Websites
Cook Biotech, Inc. announced today that its corporate website, http://www.cookbiotech.com, and its Small Intestinal Submucosa (SIS) Technology website http://www.cooksis.com have been enhanced to provide easier access for patients seeking information about SIS bioscaffolds and for physicians searching for product data and ordering information.
Read Full Article (August 22, 2003)

Cook Biotech expands in Purdue Research Park, adds high-tech jobs
Groundbreaking ceremonies today (Wednesday, 5/7) mark a new phase in the growth of Cook Biotech Inc., the Purdue Research Park and the biotechnology business base in the state of Indiana.
Read Full Article (May 12, 2003)

HEALTHPOINT® Launches OASIS® Burn Matrix
HEALTHPOINT, Ltd., a market leader in pharmaceutical products for skin and soft tissues, has announced the nationwide availability of the OASIS® Burn Matrix, a product that provides a supportive environment to allow healing of second degree and superficial burns.
Read Full Article (April 9, 2003)

Cook Incorporated Introduces Mesh for Inguinal Hernia Repair
Surgisis® IHM™, a cost-effective inguinal hernia matrix device specifically configured for use in reinforcing soft tissue during both open and laparoscopic repair of an inguinal hernia, is now available from Cook Incorporated.
Read Full Article (March 12, 2003)

Cook Biotech Becomes an Educational Partner with the Georgia Tech/ Emory Center for the Engineering of Living Tissues
Cook Biotech Incorporated is pleased to announce a recently established partnership with the Georgia Tech/Emory Center for the Engineering of Living Tissues (GTEC).
Read Full Article (February 18, 2003)

Cook Biotech and Purdue Research Foundation Settle Licensing Dispute Over Biomaterial Rights
Cook Biotech Incorporated and the Purdue Research Foundation (PRF) have signed an agreement settling legal and financial issues between the two parties relating to Cook’s license to develop commercial medical products from bioscaffolds discovered by Purdue University scientists. This settlement includes dismissal of the lawsuit pending between the parties.
Read Full Article (February 6, 2003)

HEALTHPOINT’s Oasis® Wound Matrix Product Receives Conditional Letter of Inclusion in 2004 United States Pharmacopoeia
HEALTHPOINT, Ltd., a Texas-based market leader in tissue management, dermatology, and surgical products, has announced that the OASIS® Wound Matrix has received a conditional letter of inclusion for publication United States Pharmacopoeia (USP).
Read Full Article (February 4, 2003)

Edwards Lifesciences, COOK Biotech Announce Agreement Related to Engineered Tissue Technologies
Edwards Lifesciences Corporation (NYSE: EW), a global leader in products and technologies to treat advanced cardiovascular disease, and Cook Biotech Incorporated, a leading developer of tissue-engineered biomaterials, announced today that the companies have entered into exclusive technology licensing and supply agreements to pursue the development of tissue-engineered heart valves and related cardiovascular implants using proprietary biomaterials developed by Cook Biotech.
Read Full Article (December 10, 2002)

Cook Biotech Incorporated Signs Agreement with TriOak Foods
Cook Biotech Incorporated has signed a special supply agreement with TriOak Foods Incorporated, a leading innovator in the swine industry.
Read Full Article (November 19, 2002)

Cook Biotech Incorporated Sues Competitor Alleging Patent Infringement
Cook Biotech Incorporated has filed a patent infringement lawsuit against Organogenesis Inc. of Canton, Massachusetts, charging Organogenesis with infringement of U.S. Patent No. 5,573,784 directed to a graft for promoting autogenous tissue growth.
Read Full Article (June 12, 2002)

Patent Granted for Neurological Graft Made From A Tissue-Engineered Biomaterial
Cook Biotech Incorporated has a license to new technology covered by a recently issued U.S. patent.
Read Full Article (April 4, 2002)

Oasis® Wound Matrix Recognized by the American Podiatric Medical Association
OASIS® Wound Dressing from COOK® has been recognized by the American Podiatric Medical Association (APMA) as meeting the standards for the association’s coveted Seal of Approval, Cook officials announced today.
Read Full Article (January 17, 2002)

 back |  top | learn more